Summary
Synopsys Inc. reported its financial results for the quarter and six months ended April 30, 2019. For the second quarter of fiscal year 2019, total revenue increased by 8% year-over-year to $836.2 million. This growth was driven by strong performance in both the Semiconductor & System Design segment and the Software Integrity segment, with the latter showing a significant 23% revenue increase. Despite revenue growth, operating income saw a slight decrease of 9% to $115.5 million, attributed to increased operating expenses, including a rise in restructuring charges and R&D investments to support future growth. The adoption of ASC 606, the new revenue recognition standard, had a noticeable impact, particularly on upfront revenue recognition, leading to a decrease in reported net income for the quarter compared to what would have been reported under the previous standard. The company maintained a strong balance sheet, with total assets of $6.19 billion and a significant cash and cash equivalents balance of $631.2 million. Management expressed confidence in the company's liquidity and ability to meet its obligations, supported by operational cash flow and available credit facilities.
Financial Highlights
56 data points| Revenue | $836.24M |
| Cost of Revenue | $190.68M |
| Gross Profit | $645.56M |
| R&D Expenses | $290.30M |
| Operating Expenses | $530.06M |
| Operating Income | $115.50M |
| Interest Expense | $3.84M |
| Net Income | $118.21M |
| EPS (Basic) | $0.79 |
| EPS (Diluted) | $0.77 |
| Shares Outstanding (Basic) | 149.71M |
| Shares Outstanding (Diluted) | 153.90M |
Key Highlights
- 1Total revenue for Q2 FY2019 increased by 8% year-over-year to $836.2 million.
- 2Software Integrity segment revenue surged by 23% year-over-year, indicating strong growth in this area.
- 3Operating income decreased by 9% to $115.5 million due to increased operating expenses, including restructuring charges.
- 4The company adopted ASC 606, impacting revenue recognition and leading to a $11.8 million decrease in net income compared to the previous standard for the quarter.
- 5Cash and cash equivalents stood at $631.2 million as of April 30, 2019.
- 6Research and Development expenses increased by 15% year-over-year, reflecting continued investment in innovation.
- 7The company maintained compliance with its financial covenants under its credit facilities.